Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Merck €3.4 billion notes offering
The investment-grade notes offering consists of four tranches
KKR ¥91.4 billion senior notes offering
The investment-grade notes offering consists of five tranches
Perspective Therapeutics $80 million offering
The stock is listed on the NYSE American
Cencosud $650 million senior notes offering
The senior notes are due 2031
Mirion Technologies warrant redemption
We advised Mirion Technologies on the redemption of its public warrants
The Baldwin Group $600 million senior secured notes offering and $1.44 billion credit facilities
We advised The Baldwin Group on the financing
Cloud Software Group $1.8 billion notes offering
The high-yield notes are due 2032
CRH $1.5 billion guaranteed notes offering
The investment-grade notes are due 2029 and 2034
Gates Industrial $329 million secondary offering
The offering involved 20.125 million ordinary shares
Comcast $3.25 billion notes offering
We advised Comcast in connection with the offering